Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
13m
GSK says RSV vaccine protects against disease over three seasons
Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and ...
53m
Why Pfizer will find it hard to appease its activist investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
North Dakota wildfires
Kemp suspends GA mayor
Medical copter crash kills 3
Sex abuse case dismissed
Human life expectancy study
Tickets to climb to $5
Ranger dies during rescue
Harris on '60 Minutes'
US overdose deaths drop
Richest female musician
King named grand marshal
To replace lead water pipes
States sue TikTok
Hamas backers sanctioned
Grammy-winning singer dies
SCOTUS denies appeal
Israel expands offensive
NC voting rule changes
Targeted by a cyberattack
Intel defensive briefings rise
US antitrust case advances
Win Nobel Prize in physics
Hera mission launched
Settles latest civil lawsuit
Ordered to open app store
Liquidation plan approved
Athlete payments approval
Former aide charged
Related topics
GSK
Pfizer
RSV
Sanofi
United States
Feedback